|
|
|
41
|
5282F
|
T-MYCIN 0.3% OINT (ARP) TOBRAMYCIN (BH)
|
TOBRAMYCIN
|
T-MYCIN
|
3G
|
BH
|
5.38
|
5.3823
|
TUBE
|
2
|
BOX
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
5282G
|
TOBREX 0.3% EYE OINT (NVS/COL) TOBRAMYCIN
|
TOBRAMYCIN
|
TOBREX
|
3.5G
|
BH
|
15.49
|
15.49
|
EYE OINTMENT
|
0
|
TUBE
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5282G
|
TOBREX 0.3% EYE OINT (NVS) TOBRAMYC (C)
|
TOBRAMYCIN
|
TOBREX
|
3.5G
|
C
|
15.49
|
15.4944
|
TUBE
|
2
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5282G
|
TOBREX 0.3% EYE OINT (NVS) TOBRAMYC
|
TOBRAMYCIN
|
TOBREX
|
3.5G
|
C
|
15.49
|
15.49
|
TUBE
|
2
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5282J
|
TOBRACID 0.3% EYE OINT (HAN) TOBRAMYCIN
|
TOBRAMYCIN
|
TOBRACID
|
3G
|
BH
|
2.80
|
2.80
|
TUBE
|
2
|
TUBE
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
53013
|
ASPIRIN|DIPYRIDAMOLE 25MG|200MG ER (C)
|
ASPIRIN|DIPYRIDAMOLE
|
ASPIRIN|DIPYRIDAMOLE
|
60'S
|
C
|
103.2963
|
1.7216
|
CAPER
|
0
|
BOX
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
CWS
|
CAPSULE WHOLESALE
|
|
2412
|
VASODILATING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
VASODILATING AGENTS
|
|
|
|
|
40
|
53116
|
PENICILLAMINE 250MG CAP (SLS/AHI)
|
PENICILLAMINE
|
PENICILLAMINE
|
50'S
|
A
|
150.32
|
3.01
|
CAPSULE
|
180
|
CAP
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
41
|
53117
|
PENICILLAMINE 250MG CAP (JOL)
|
PENICILLAMINE
|
PENICILLAMINE
|
50'S
|
A
|
70.49
|
1.4097
|
CAP
|
180
|
BOX
|
JOL
|
JOLLY PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
42
|
53117
|
PENICILLAMINE 250MG CAP (JOL)
|
PENICILLAMINE
|
PENICILLAMINE
|
50'S
|
A
|
46.48
|
0.93
|
CAP
|
180
|
BLIS
|
JOL
|
JOLLY PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
6400
|
HEAVY METAL ANTAGONISTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
HEAVY METAL ANTAGONISTS
|
|
|
|
|
41
|
5422G
|
TOBRAMYCIN 40MG/ML INJ (DIL) (BQ)
|
TOBRAMYCIN
|
TOBRAMYCIN
|
25X2ML
|
BQ
|
482.39
|
19.2958
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081202
|
AMINOGLYCOSIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
AMINOGLYCOSIDES
|
|
|
|
|
40
|
5422J
|
TOCIN 40MG/ML INJ (UBI/RXP) TOBRAMYCIN
|
TOBRAMYCIN
|
TOCIN
|
2ML VIAL
|
BQ
|
8.97
|
8.97
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
081202
|
AMINOGLYCOSIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
54814
|
TINIREM 500MG TAB (REM) TINIDAZOLE
|
TINIDAZOLE
|
TINIREM
|
10X4
|
A
|
8.83
|
0.2209
|
TAB
|
8
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTIPROTOZOALS, MISCELLANEOUS
|
|
|
|
|
42
|
54814
|
TINIREM 500MG TAB (REM) TINIDAZOLE
|
TINIDAZOLE
|
TINIREM
|
10X4
|
A
|
8.97
|
0.22
|
TAB
|
14
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTIPROTOZOALS, MISCELLANEOUS
|
|
|
|
|
40
|
5481Q
|
TINIDAZOLE 500MG TAB (LAF/AHI)
|
TINIDAZOLE
|
TINIDAZOLE
|
40'S
|
A
|
38.65
|
0.97
|
TABLET
|
8
|
TAB
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-02-03
|
|
|
|
40
|
55011
|
AROMASIN 25MG TAB (PFI/STO) EXEMESTANE
|
EXEMESTANE
|
AROMASIN
|
30'S
|
C
|
259.76
|
8.66
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
55011
|
AROMASIN 25MG TAB (PFI) EXEMESTANE (C)
|
EXEMESTANE
|
AROMASIN
|
30'S
|
C
|
259.76
|
8.6588
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
55011
|
AROMASIN 25MG TAB (PFI) EXEMESTANE
|
EXEMESTANE
|
AROMASIN
|
30'S
|
C
|
259.76
|
8.66
|
TAB
|
30
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
55015
|
EXEMESTANE 25MG TAB (REM) (BQ)
|
EXEMESTANE
|
EXEMESTANE
|
30'S
|
BQ
|
11.53
|
0.3842
|
TAB
|
30
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
55015
|
EXEMESTANE 25MG TAB (REM)
|
EXEMESTANE
|
EXEMESTANE
|
30'S
|
BQ
|
18.24
|
0.61
|
TAB
|
30
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
55018
|
EXETAS 25MG TAB (INP/AHI) EXEMESTANE
|
EXEMESTANE
|
EXETAS
|
3X10
|
BQ
|
223.12
|
7.44
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
